Regenerative medicine and biomaterials

Most active in this area

• UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE AMEDEO AVOGADRO

  Italian university combining nanosafety science with regenerative medicine — from nanomaterial risk assessment to organ-on-chip and 3D bioprinted therapies.

  “Core expertise demonstrated across HemAcure (gene/cell therapy devices), RESTORE (nanobiomaterial cartilage repair), PREMUROSA (musculoskeletal regeneration), VANGUARD (bioartificial pancreas), and ExcellMater (biomaterials characterization).”

  PrimaryIT21 projects
• UNIVERSITA HUMANITAS

  Italian biomedical university specializing in immunology, epigenetics, and inflammatory disease — from molecular mechanisms to clinical diagnostics and therapy.

  “MEFISTO project on 3D biofunctionalised meniscal scaffolds to prevent osteoarthritis, representing a newer direction in personalized orthopedic treatment.”

  IT14 projects
• ECOLE NATIONALE VETERINAIRE, AGROALIMENTAIRE ET DE L'ALIMENTATION NANTES ATLANTIQUE

  French veterinary and food science school specializing in animal health, food safety risk assessment, and analytical chemistry for hazard detection.

  “Third-party contributor to iPSpine on induced pluripotent stem cells for spinal disc regeneration, reflecting their veterinary medicine research capacity.”

  FR9 projects
• Catalyze B.V.

  Dutch health research SME providing clinical research support, health economics, and patient engagement services across cardiovascular, regenerative medicine, and integrated care projects.

  “iPSpine project focused on induced pluripotent stem cell-based therapy for spinal disc regeneration.”

  SMENL4 projects
• NTRANS TECHNOLOGIES BV

  Dutch biotech SME with proprietary intracellular delivery technology (iTOP kit) applied to iPSC reprogramming and spinal regenerative medicine.

  “iPSpine targets spinal disc regeneration using iPSC-based therapies combined with biomaterials, areas where NTRANS contributes as a technology partner.”

  SMENL2 projects